Collabra Pharma

Collabra Pharmaceuticals is a specialty pharmaceutical company based in Morrisville, North Carolina, focused on the development and commercialization of products using the FDA's 505(b)(2) regulatory pathway. The company specializes in reformulating existing off-patent drugs to address unmet medical needs, such as improving patient compliance or providing alternative dosage forms. Their lead product, CP-101, is an oral solution of methimazole indicated for the treatment of hyperthyroidism, providing a liquid alternative to traditional tablet forms. Collabra leverages its expertise in formulation and clinical development to bring high-value, late-stage products to market efficiently.